Physician

Shannon Courtney O'Connor, M.D.

According to 2025 Medicare claims, Shannon O'Connor, M.D. (NPI: 1972760452) practices hematology/oncology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is MARYLAND ONCOLOGY HEMATOLOGY, P.A. (NPI: 1821271032; TIN: 113652573) and primary practice location at 20850-6535.

O'Connor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 699 traditional Medicare patients, billed 117,970 HCPCS/CPT codes, and received $2,086,014 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 565 prescription claims across 135 beneficiaries totaling $1,309,108 in drug costs, led by Ibrance (Palbociclib). DME data shows 57 claims. Open Payments data shows 120 records totaling $156,479. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,013,022 to $2,086,014. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $349,548 to $1,309,108. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.1M2015 Medicare payment: $1,013,022 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,290,122 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,350,912 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,258,688 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,590,238 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $760,125 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,426,166 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,504,990 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,901,707 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,086,014 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201551883,978$1,013,022
201674990,394$1,290,122
20173,44890,186$1,350,912
20182,47970,646$1,258,688
2019624113,614$1,590,238
202042858,431$760,125
2021581110,107$1,426,166
2022621110,321$1,504,990
2023688142,273$1,901,707
2024699117,970$2,086,014

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$655K$1.3M2015 Drug cost: $349,548 (USD; Tot_Drug_Cst)2016 Drug cost: $202,136 (USD; Tot_Drug_Cst)2017 Drug cost: $358,659 (USD; Tot_Drug_Cst)2018 Drug cost: $430,476 (USD; Tot_Drug_Cst)2019 Drug cost: $593,074 (USD; Tot_Drug_Cst)2020 Drug cost: $689,732 (USD; Tot_Drug_Cst)2021 Drug cost: $774,855 (USD; Tot_Drug_Cst)2022 Drug cost: $782,549 (USD; Tot_Drug_Cst)2023 Drug cost: $904,534 (USD; Tot_Drug_Cst)2024 Drug cost: $1,309,108 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201575406$349,548
201677356$202,136
201763282$358,659
201868301$430,476
201978304$593,074
202074326$689,732
2021103392$774,855
2022115478$782,549
2023129492$904,534
2024135565$1,309,108

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$6.9K$14K2015 Medicare payment: $9,011 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $3,048 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $768 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $13,885 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $926 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R107$9,011
2016N/R46$3,048
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/R28$768
2023N/R34$13,885
2024N/R57$926

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less95227$117
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more247440$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more209258$72
80053Blood test, comprehensive group of blood chemicals235756$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count261978$8

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
IbrancePalbociclib25700$381,540
KisqaliRibociclib Succinate18504$272,216
ImbruvicaIbrutinib13364$212,243
BrukinsaZanubrutinib12360$177,935
EliquisApixaban282,220$43,226

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J8521Capecitabine, oral, 500 mgNN/R24$412
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R19$339
Q0512Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day periodNN/R14$176

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$373Tempus AI, Inc
Research PaymentsReported research-related payment or transfer-of-value amount.110$156,105Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Shannon Courtney O'Connor, M.D.?

Tedicare shows public-source Medicare data for Shannon Courtney O'Connor, M.D. (NPI 1972760452), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Shannon Courtney O'Connor, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Shannon Courtney O'Connor, M.D.?

Shannon Courtney O'Connor, M.D. is linked to MARYLAND ONCOLOGY HEMATOLOGY, P.A. (billing NPI 1821271032) in the available physician profile data.

Does Shannon Courtney O'Connor, M.D. have Open Payments data?

Shannon Courtney O'Connor, M.D. has 120 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.